Tag: Office of Policy Planning

The Federal Trade Commission marked the one-year anniversary of a government-wide effort to implement President Biden’s Executive Order on Promoting Competition in the American Economy. Over the past...

The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients’ access to competing lower-cost drugs. The enforcement policy...

The Federal Trade Commission will host another listening forum to hear from those who have experienced firsthand the effects of mergers and acquisitions. The June 21 forum will be attended by FTC...

The Federal Trade Commission and the U.S. Department of Justice (DOJ) will host a two-day workshop starting tomorrow, that explores new approaches to enforcing the antitrust laws in the pharmaceutical...

The Federal Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information...

The Federal Trade Commission and the U.S. Department of Justice (DOJ) will host a two-day workshop to explore new approaches to enforcing the antitrust laws in the pharmaceutical industry. The...

Today, the Federal Trade Commission staff launched an inquiry into the ongoing shortage for infant formula that has caused hardship for countless American families. The inquiry seeks information about...

The Federal Trade Commission today called for research presentations on a wide range of privacy and data security topics such as commercial surveillance and automated decision making for its annual...

Federal Trade Commission Chair Lina M. Khan announced the appointment of two senior agency leaders: General Counsel Anisha Dasgupta and Office of Policy Planning Director Elizabeth Wilkins. “I’m...

The Federal Trade Commission is extending the public comment period, until May 25, 2022, on a request for information that covers a wide range of issues in the PBM market – including contract terms...

Today, the Federal Trade Commission and U.S. Department of Justice are extending by one month the deadline to submit comments as part of the enforcement agencies’ process to modernize the merger...

The Federal Trade Commission announced it is soliciting public input on the ways that practices by large, vertically integrated Pharmacy Benefit Managers’ (PBMs) are affecting drug affordability and...

The Federal Trade Commission staff has submitted a comment to the Food and Drug Administration (FDA) in response to FDA’s request for comment on its proposed rule on establishing over-the-counter...

The Federal Trade Commission has announced an agenda for its upcoming virtual workshop regarding competition in labor markets. First announced on Oct. 27, 2021, “ Making Competition Work: Promoting...

The Federal Trade Commission voted to withdraw its approval of the Vertical Merger Guidelines, issued jointly with the Department of Justice (DOJ), and the FTC’s Vertical Merger Commentary. The...

At an open Commission meeting today, the Federal Trade Commission staff presented findings from its inquiry into past acquisitions by the largest technology platforms’ that did not require reporting...